Genetic and epigenetic drivers of neuroendocrine tumours (NET) A Di Domenico, T Wiedmer, I Marinoni, A Perren Endocrine-related cancer 24 (9), R315-R334, 2017 | 125 | 2017 |
Epistasis-driven identification of SLC25A51 as a regulator of human mitochondrial NAD import E Girardi, G Agrimi, U Goldmann, G Fiume, S Lindinger, V Sedlyarov, ... Nature communications 11 (1), 6145, 2020 | 87 | 2020 |
The RESOLUTE consortium: unlocking SLC transporters for drug discovery G Superti-Furga, D Lackner, T Wiedmer, A Ingles-Prieto, B Barbosa, ... Nature reviews Drug discovery 19 (7), 429-430, 2020 | 71 | 2020 |
Autophagy inhibition improves sunitinib efficacy in pancreatic neuroendocrine tumors via a lysosome-dependent mechanism T Wiedmer, A Blank, S Pantasis, L Normand, R Bill, P Krebs, MP Tschan, ... Molecular cancer therapeutics 16 (11), 2502-2515, 2017 | 63 | 2017 |
Three-dimensional primary cell culture: a novel preclinical model for pancreatic neuroendocrine tumors SL April-Monn, T Wiedmer, M Skowronska, R Maire, M Schiavo Lena, ... Neuroendocrinology 111 (3), 273-287, 2021 | 41 | 2021 |
An overview of cell-based assay platforms for the solute carrier family of transporters V Dvorak, T Wiedmer, A Ingles-Prieto, P Altermatt, H Batoulis, F Bärenz, ... Frontiers in pharmacology 12, 722889, 2021 | 38 | 2021 |
Hypo-methylation mediates chromosomal instability in pancreatic NET I Marinoni, A Wiederkeher, T Wiedmer, S Pantasis, A Di Domenico, ... Endocr. Relat. Cancer 24 (3), 137-146, 2017 | 28 | 2017 |
Assessing autophagy in archived tissue or how to capture autophagic flux from a tissue snapshot M Humbert, M Morán, P de la Cruz-Ojeda, J Muntané, T Wiedmer, ... Biology 9 (3), 59, 2020 | 17 | 2020 |
Gain-of-function genetic screens in human cells identify SLC transporters overcoming environmental nutrient restrictions M Rebsamen, E Girardi, V Sedlyarov, S Scorzoni, K Papakostas, M Vollert, ... Life Science Alliance 5 (11), 2022 | 9 | 2022 |
Accelerating SLC transporter research: streamlining knowledge and validated tools T Wiedmer, A Ingles‐Prieto, U Goldmann, CM Steppan, G Superti‐Furga Clinical Pharmacology and Therapeutics 112 (3), 439, 2022 | 7 | 2022 |
Impedance-based phenotypic readout of transporter function: a case for glutamate transporters HJ Sijben, L Dall’Acqua, R Liu, A Jarret, E Christodoulaki, S Onstein, ... Frontiers in Pharmacology 13, 872335, 2022 | 4 | 2022 |
Experimental and computational analysis of newly identified pathogenic mutations in the creatine transporter SLC6A8 E Ferrada, T Wiedmer, WA Wang, F Frommelt, B Steurer, C Klimek, ... Journal of Molecular Biology 436 (2), 168383, 2024 | 2 | 2024 |
Transport and inhibition of the sphingosine-1-phosphate exporter SPNS2 D Sauer, H Li, A Pike, YN Chang, D Prakaash, Z Gelova, J Stanka, ... | 1 | 2023 |
Image-based quantification of mitochondrial iron uptake via Mitoferrin-2 M Polesel, MHE Wildschut, C Doucerain, M Kuhn, A Flace, AL Steck, ... Mitochondrion, 101889, 2024 | | 2024 |
An Overview of Cell-Based Assay Platforms for the Solute Carrier Family of Transporters. Front. Pharmacol. 12: 722889. doi: 10.3389/fphar. 2021.722889 V Dvorak, T Wiedmer, A Ingles-Prieto, P Altermatt, H Batoulis, F Bärenz, ... Frontiers in Pharmacology| www. frontiersin. org 12, 2021 | | 2021 |
Epigenetic changes in DAXX and/or ATRX negative pancreatic neuro-endocrine tumours A Di Domenico, C Pipinikas, C Simillion, T Wiedmer, R Maire, C Thirlwell, ... VIRCHOWS ARCHIV 473, S2-S2, 2018 | | 2018 |
Epigenetic Changes in DAXX and/or ATRX Negative Pancreatic Neuro-Endocrine Tumors A Di Domenico, C Pipinikas, C Simillion, T Wiedmer, R Maire, C Thirlwell, ... NEUROENDOCRINOLOGY 106, 28-28, 2018 | | 2018 |
Lysosomal membrane permeabilization as potential mediator of resistance in pancreatic neuroendocrine tumors T Wiedmer, RM Frank, MP Tschan, A Perren, I Marinoni Cancer Research 77 (13_Supplement), 3159-3159, 2017 | | 2017 |
Autophagy Inhibition Improves Current Pancreatic Neuroendocrine Tumor Therapy Via a Lysosome-dependent Mechanism T Wiedmer Medizinische Fakultät der Universität Bern, 2017 | | 2017 |
3D Primary Cell Culture: A New Promising Preclinical Model for Pancreatic Neuro-Endocrine Tumors (pNETs) I Marinoni, C Mooser, T Wiedmer, A Di Domenico, S Pantasis, A Blank, ... NEUROENDOCRINOLOGY 105, 31-31, 2017 | | 2017 |